TransCode Therapeutics Announces Cost-Cutting Measures, Shifts Focus to Phase 1 Trial, CEO Retirement

The restructuring is intended to further reduce expenditures and enable greater concentration of company resources on a planned Phase 1 clinical trial for ...

January 15, 2024 | Monday | News
VantAI Renews Partnership with Blueprint Medicines for Innovative Drug Discovery

-- VantAI’s advanced geometric deep learning platform will be used to generate innovative proximity modulating therapeutics, including molecular glue...

January 10, 2024 | Wednesday | News
Valneva Begins Pediatric Trial for Single-Shot Chikungunya Vaccine

The Company reported positive pivotal Phase 3 data in adolescents two months ago confirming the immunogenicity and safety profile observed in adults1.There...

January 10, 2024 | Wednesday | News
Omniose Joins Forces with AstraZeneca for Breakthrough Research on Vaccines for Severe Bacterial Diseases

Omniose, a preclinical stage biotechnology company, today announced an exclusive collaboration agreement with AstraZeneca for the search for potential vacc...

January 08, 2024 | Monday | News
Curevo Vaccine Triumphs in Phase 2 Trial: Amezosvatein Beats Shingrix in Shingles Showdown!

- Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein met the primary immunogenicity endpoint, eliciting a robust imm...

January 08, 2024 | Monday | News
Allogene Therapeutics, Foresight Diagnostics Partner for MRD-Based Diagnostic in ALPHA3 Trial for Large B-Cell Lymphoma

Allogene Therapeutics Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) product...

January 05, 2024 | Friday | News
ReCode Therapeutics Begins Phase 1 Trial for mRNA Therapy in Primary Ciliary Dyskinesia

RCT1100 is the first clinical evaluation of an inhaled mRNA-based therapy designed to restore ciliary function in people with PCD -ReCode Th...

January 04, 2024 | Thursday | News
Citius Pharma Completes Enrollment in Phase 3 Trial for Mino-Lok® Catheter Salvage

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercial...

January 03, 2024 | Wednesday | News
Junshi Biosciences Gets Approval for Toripalimab as Perioperative Treatment in Resectable NSCLC

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company ded...

January 03, 2024 | Wednesday | News
Avenue Therapeutics Completes Enrollment in Clinical Trial for AJ201 in Kennedy's Disease

Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development...

January 03, 2024 | Wednesday | News
BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients

71% intracranial objective response rate (iORR) in BriaCell patients with Central Nervous System (CNS) metastases support clinical efficacy of Bria-IMT&t...

January 01, 2024 | Monday | News
NKGen Biotech Initiates Phase 1/2a Trial for Alzheimer’s with SNK01 NK Cell Product

SNK01 consists of a non-genetically modified NK cell product with enhanced cytotoxicity and activating receptor expression for the treatment of moderate AD...

January 01, 2024 | Monday | News
Enveric Biosciences Updates Year-End Progress on Lead Prodrug Candidate EB-373

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neur...

December 28, 2023 | Thursday | News
Innovent, Xuanzhu Collaborate on Clinical Trial for Advanced Solid Tumors in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

December 28, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close